In this new role Kuznetsov will be responsible for the generic pharmaceutical category to improve profits by driving a consistent and comprehensive strategy. Adding to his current responsibilities with generic sourcing, he will assume responsibility for the commercialization of generics. This will allow Kuznetsov to continue to deliver incremental value and still lead H. D. Smith’s generic sourcing activities. In his expanded role, Kuznetsov will help develop programs and pricing initiatives that will optimize generics for H. D. Smith’s customers.
Kuznetsov joined H. D. Smith in 2012 as vice president, generic pharmaceuticals sourcing, and was responsible for the development, implementation and management of the generic pharmaceuticals sourcing strategy. He led the team in establishing key strategic relationships with trading partners that have resulted in H. D. Smith’s competitive generics portfolio. In addition, his team was able to negotiate improved terms and conditions with top trading partners that have allowed H. D. Smith to be contemporary with contracts.
About H. D. Smith
H. D. Smith is the largest, privately held national wholesaler, with a complete line of healthcare products and solutions to improve patient care. The company creates value and an extraordinary customer experience by impacting the healthcare supply chain. Bridging the gap between manufacturer and patient, H. D. Smith’s specialty solutions division offers a unique suite of strategic programs for patient access on behalf of pharmaceutical suppliers. Headquartered in Springfield, Illinois, H. D. Smith also operates CompleteCare Pharmacy, Smith Medical Partners, Triplefin and Valley Wholesale Drug.